Ati cautat: pacienti boli rare
Protocol terapeutic: L01XE23-25 – DCI DABRAFENIBUM + DCI TRAMETINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE15 – DCI VEMURAFENIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC17 – DCI NIVOLUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L02BB04 – DCI ENZALUTAMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE02 – DCI GEFITINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE24 – DCI PONATINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC15 – DCI OBINUTUZUMAB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Cercetatorii britanici anunta ca au descoperit cauza sclerozei multiple
In 2017 vor beneficia de programele nationale de sanatate curative peste un milion de bolnavi (CNAS)
Studiu: Testul care poate diagnostica tuberculoza in cateva ore
